Skip to content
    Valtruis logo

    Valtruis

    Chicago, Illinois, United StatesFounded 2021

    Valtruis is a venture and growth-stage investment platform backed by Welsh, Carson, Anderson & Stowe (WCAS) that invests in, builds, and partners with healthcare companies focused on value-based care. The firm supports companies from early-stage development through industry-leading enterprises.

    72% of their portfolio is in Healthcare. Their most common stage is series-b (48% of deals). Average disclosed round size is $46.3M (across 22 rounds with reported amounts).

    Find people at Valtruis on Goldilocks AI

    Portfolio

    15

    Fund Size

    $300M

    Top Stage

    Series B

    Last 12 Mo

    3

    Team

    AH

    Anna Haghgooie

    Managing Director

    KW

    Karey Witty

    Managing Director

    MS

    Mike Spadafore

    Managing Director

    TB

    Tracy Bahl

    Managing Director

    CP

    Callie Patel

    Senior Vice President

    CL

    Corey Lenhoff

    Vice President

    JB

    Jess Bossmann

    Vice President

    MS

    Manav Sarkaria

    Vice President

    Claire McGee Sharma

    Claire McGee Sharma

    Associate

    EM

    Erin Murphy

    Executive Assistant

    Miriam de Leon Diaz

    Miriam de Leon Diaz

    Executive Assistant

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    25 investments
    CompanyRoundAmountDate
    InStride Health logoInStride HealthSeries C$30MJun 2026
    InStride logoInStrideSeries C$30MJun 2026
    Nadia logoNadiaUnknown$12MMar 2026
    Sevaro logoSevaroSeries B$39MSep 2025
    Arbital Health logoArbital HealthSeries B$31MJul 2025
    AArbitalSeries B—Jul 2025
    Sevaro logoSevaroSeries B$39MJan 2025
    HarmonyCares logoHarmonyCaresSeries D$200MJul 2024
    AAtroposSeries B$33MMay 2024
    Wayspring logoWayspringUnknown—May 2024
    InStride Health logoInStride HealthSeries B$30MMar 2024
    InStride Health logoInStride HealthSeries B$30MMar 2024
    Arbital Health logoArbital HealthSeries A$10MJan 2024
    InStride Health logoInStride HealthSeries B$30MJan 2024
    InStride logoInStrideSeries B$30MJan 2024
    IInStride Health, Inc.Series B$30MJan 2024
    InStride Health logoInStride HealthSeries B$30MJan 2024
    WWellvana HealthGrowth—Mar 2023
    Wellvana logoWellvanaUnknown$84MJan 2023
    IInStride Health, Inc.Series C$30MJan 2022
    Wayspring logoWayspringGrowth$75MSep 2021
    Cricket Health logoCricket HealthSeries B$83.5MAug 2021
    Wellvana logoWellvanaUnknown$84MJan 2020
    Autonomize logoAutonomizeSeries A$28M—
    InStride Health logoInStride HealthSeries C$30M—

    Top Co-Investors

    Last updated: 20 October 2026